Q2 2026 net sales rose to $2,803m (+3.3%, +1.0% organic), but profitability was uneven: operating margin was 6.8% (9.6% adjusted) while diluted EPS fell to $1.35, down 38%. Overall, the report points to modest revenue momentum offset by a significant earnings decline, likely keeping investors cautious into the full-year outlook.
Q2 2026 net sales rose to $2,803m (+3.3%, +1.0% organic), but profitability was uneven: operating margin was 6.8% (9.6% adjusted) while diluted EPS fell to $1.35, down 38%. Overall, the report points to modest revenue momentum offset by a significant earnings decline, likely keeping investors cautious into the full-year outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.15
